Personal information

Verified email domains

Activities

Employment (3)

Zhongshan Hospital: Shanghai, CN

Doctor (Department of Liver Surgery and Transplantation)
Employment
Source: Self-asserted source
Yinghong Shi

Liver Cancer Institute: Shanghai, CN

(Department of Liver Surgery)
Employment
Source: Self-asserted source
Yinghong Shi

Chinese Academy of Medical Sciences: Beijing, CN

Professor (Research Unit of Liver Cancer Recurrence and Metastasis)
Employment
Source: Self-asserted source
Yinghong Shi

Works (5)

Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis

BMJ Oncology
2024-12 | Journal article
Contributors: Hui-Chuan Sun; Xiao-Dong Zhu; Zi-Yi Wang; Qiang Gao; Yuan Ji; Ying-Hong Shi; Xiao-Ying Wang; Shuang-Jian Qiu; Cheng Huang; Ying-Hao Shen et al.
Source: check_circle
Crossref

SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial–mesenchymal transition and mitochondrial function maintenance

Cancer Medicine
2023-01 | Journal article
Contributors: Jiafeng Chen; Zheng Gao; Xiaogang Li; Yinghong Shi; Zheng Tang; Weiren Liu; Xin Zhang; Ao Huang; Xuanming Luo; Qiang Gao et al.
Source: check_circle
Crossref

Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting

Korean Journal of Radiology
2022 | Journal article
Contributors: Cher Heng Tan; Shu-cheng Chou; Nakarin Inmutto; Ke Ma; RuoFan Sheng; YingHong Shi; Zhongguo Zhou; Akira Yamada; Ryosuke Tateishi
Source: check_circle
Crossref

HNRNPAB‐regulated lncRNA‐ELF209 inhibits the malignancy of hepatocellular carcinoma

International Journal of Cancer
2020-01 | Journal article
Contributors: Yi Yang; Qing Chen; Hai‐Yan Piao; Biao Wang; Gui‐Qi Zhu; Er‐Bao Chen; Kun Xiao; Zheng‐Jun Zhou; Guo‐Ming Shi; Ying‐Hong Shi et al.
Source: check_circle
Crossref

Doctor

Technical Standard
Source: Self-asserted source
Yinghong Shi